Is it necessary to use three mandatory loading doses when commencing therapy for neovascular age-related macular degeneration using bevacizumab? (BeMOc Trial)
| Image |  |
|---|---|
| Description | scientific article published on 07 June 2013 |
| Author/s |
author: Sobha Sivaprasad |
| Publication date | June 7, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |